Details for New Drug Application (NDA): 065364
✉ Email this page to a colleague
The generic ingredient in COLISTIMETHATE SODIUM is colistimethate sodium. There are two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the colistimethate sodium profile page.
Summary for 065364
Tradename: | COLISTIMETHATE SODIUM |
Applicant: | Fresenius Kabi Usa |
Ingredient: | colistimethate sodium |
Patents: | 0 |
Suppliers and Packaging for NDA: 065364
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
COLISTIMETHATE SODIUM | colistimethate sodium | INJECTABLE;INJECTION | 065364 | ANDA | Fresenius Kabi USA, LLC | 63323-393 | 63323-393-06 | 1 VIAL in 1 BOX (63323-393-06) / 2 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 150MG BASE/VIAL | ||||
Approval Date: | Apr 17, 2008 | TE: | AP | RLD: | No |
Complete Access Available with Subscription